Array
(
    [var] => cut_url
)
<pre>Array ( [var] => cut_url ) </pre> Resume for Haro H. for Executive Manager / Biotechnology & Pharmaceuticals in Edgewater, New Jersey. Search More Resumes for Executive Manager on Resumark.com #T4JNRDY3L
 

Search Resumes

Post Jobs
 


Job Seekers:
Post Your Resume


 

Resume for Haro H. for Executive Manager / Biotechnology & Pharmaceuticals in Edgewater, New Jersey




Occupation: Executive Manager Industry: Biotechnology & Pharmaceuticals
Country: United States City: Edgewater
State: New Jersey ZIP: 07020



View Complete Resume   Download Resume [
Array
(
    [name] => cut_url
)
PDF]
Share Share


< Back to search results Preview: For the complete resume and contact info please download it.

Array
(
    [var] => content
    [type] => preview
)
Array
(
    [var] => cut_url
)
Haro H., Ph.D.
Daibes Court ? Edgewater, NJ ? ?
CEO / COO / President / General Manager Pharmaceutical, Biotechnology, Medical
Device
Scientific and Business Executive with a record of achieving aggressive goals in large pharmaceutical, startup
biotechnology, and medical device companies by positioning capital, people, intellectual property, systems, and
internal disciplines for successful long term growth.
Accomplished entrepreneur with business leadership experience and solid scientific background to drive
products from bench to commercialization. Achieved aggressive product development goals by positioning
capital, people, intellectual property, systems, corporate partnerships, and internal disciplines for successful long
term growth. Key player in development of two FDA approved products DepoCyt and DepoMorphine from
bench to commercial launch.
Areas of Leadership Expertise:
|Visionary & Strategic Leadership |Team Building & Leadership |Business Development |
|Aggressive Product Development |Company Image & Visibility |Corporate Partners & JVs |
|IPO & Shareholders Value |Seed and Future Fund Raising |Product Pipeline Development |
|Debt Restructuring |Mergers & Acquisitions |Strategic Alliances / Equity |
| | |Investors |
Product Development Expertise:
|Diabetes |CNS Disorders |Cell Transplantation Therapy |
|Oncology |Medical Device |Drug Delivery and Biopolymers |
Ph. D. Chemical Engineering concentration in Biochemistry; M.S. / B.S. Chemical Engineering
Value Offered
Mergers & Acquisitions: As President and CEO of Vyteris, Inc., orchestrated the merger and integration of
MediSync BioServices Inc. in , and secured Board approval to exit the transdermal drug delivery business,
monetize assets, substantially reduce total liabilities, and raise $MM in equity capital for the purpose of
acquiring contract research organizations CROs.
Seed and Future Fund Raising: Led Microislet, Inc. from startup to a successful public company, negotiating
$MM in startup equity financing and generating additional funds by taking company public, resulting in
market cap increase of $MM average in months and shares traded on the American Stock Exchange.
Secured an additional $MM from NIH and $K from Juvenile Diabetes Foundation. Founded Protagenic
Therapeutics, Inc., securing $MM in seed financing from influential and established investors who are well
known in the industry. Orchestrated $MM in equity capital for Vyteris.
Business Development: At Vyteris, Inc., established business development strategies, forged partnerships, and
led strategic alliance discussions with major biopharmaceutical companies in the transdermal drug delivery
market. Inlicensed technologies to strengthen product offerings. As CEO, Director and Founder of Protagenic
Therapeutics, Inc., negotiated an exclusive licensing agreement with the University of Toronto for a
revolutionary therapeutic technology.
Public/ Private Company and Wall Street Experience: Served on both private and public company Boards of
Directors; gained tremendous Wall Street experience bringing companies public and negotiating equity deals
with investment banking firms, private equity and venture capital firms, and private investors.
Career History
VYTERIS INC. OTC/BB: VYTR, Fair Lawn, NJ
to
President and CEO
PROTAGENIC THERAPEUTICS INC,, San Diego, CA
to
President and CEO, Director and Founder
MICROISLET, INC., San Diego, CA
to
President, COO and CoFounder
MONSANTO, San Diego, CA
to
Director, Process Development
DEPOTECH CORPORATION, San Diego, CA
to
Associate Director – Process Development to
Manager – Process Development to
Senior Process Engineer to
DUPONT CENTRAL RESEARCH AND DEVELOPMENT, Wilmington, DE
to
Research Engineer
Experience and Accomplishments
VYTERIS INC. OTC/BB: VYTR, Fair Lawn, NJ
to
President and CEO
Brought in as the first external executive leader in company history with both scientific and business background,
to turn around, revitalize and refocus Vyteris and drive increased profitability and performance. Managed all
crucial areas of R&D, operations, business development, strategic partnering, product development and
commercialization, and public and investor relations. Established business development strategies, forged
partnerships, and led strategic alliance discussions with major biopharmaceutical companies. Serve as a member
of Board of Directors.
Impact: Led the company through a successful turnaround, infrastructure redesign, reorganization,
merger, and business transformation, positioning the company for growth and success in the $B
contract research organization CRO industry.
. Successfully orchestrated merger with MediSync BioServices Inc., transforming Vyteris into a diversified
and profitable specialty contract research organization CRO, while exiting from the company’s existing
drug delivery business.
. Proposed strategy and secured Board approval to raise $M in equity capital
for the purpose of acquiring four attractive CRO businesses in the areas of Dermatology, Pain
Management and Regulatory Affairs. The long term investment opportunity over years is estimated to
generate $.MM in revenue and $.MM EBITDA, growing % annually.
. Proposed strategy and secured Board approval to take the company
private, monetize Vyteris’ extensive transdermal drug delivery assets,
and reduce total liabilities from $.MM to $.MM.
. Successfully advanced company’s ongoing joint venture in development of noninvasive infertility
hormone with its corporate partner to phase clinical trials.
. Virtually transformed and renewed firm’s viability and momentum as a highpotential player in the
transdermal drug delivery market. Brought renewed focus to corporate strategy by redefining and
accelerating product development plan/cycle and inlicensing technologies to strengthen product
offerings.
. Initiated highlevel operational and business development activities, infrastructure redesign, turnaround
strategy, and reorganization. Cut headcount from to , reengineered business processes, redesigned
product development plan, and instilled urgency for financial discipline. Improved SarbanesOxley
compliant business process and reporting standards.
PROTAGENIC THERAPEUTICS INC., San Diego, CA
to
President and CEO, Director and Founder
Won licensing agreement with University of Toronto to create a biotechnology company focused on developing
treatment for central nervous systems disorders. Formulated company’s strategic direction, business plans, and
financial projections and tactics. Successfully created valuation model and secured funding. Helped to formulate
development strategy and demonstrate proofofconcept. Served as a member of Board of Directors.
Impact: Founded company based on therapeutic technology for central nervous system disorders
developed at the University of Toronto. Earned inventor’s and university officials’ respect; negotiated
exclusive license agreement.
. Secured financing from influential and established investors who are wellknown in the industry.
. Devised business plan and strategy by meeting with partners, consultants, and scientists for indepth
review and final approval. Raised sufficient funding to support company’s product development
activities.
. Assembled a world class board of directors and exemplary scientific advisory board.
. Established business development and strategic alliances discussions with major biopharmaceutical
companies.
MICROISLET, INC., San Diego, CA
to
President, COO and CoFounder
Directed startup operations of biotechnology company. Developed business plan, provided strategic direction,
raised funds, hired all personnel, forged corporate partnerships, and managed R&D activities. Provided visionary
leadership and stabilized company by establishing overall goals, policies, processes, and

Cancel
Not Enough Credits
Sorry, but you don't have enough credits to download this resume.

Purchase more credits
Not Available
Sorry but this resume is not available for download. Please choose another!

Close
Confirm Download

Would you like to download  for 1 credit?

You have  credits left.

Yes No 

Don't ask me again
Confirm View Complete Resume

Would you like to view  for 1 credit?

You have  credits left.

Yes No 

Don't ask me again